Partnerships & Mergers

The investment at Naivasha SEZ is expected to contribute to technology transfer, skills development and job creation while strengthening Kenya’s pharmaceutical manufacturing capacity.

GM2 gangliosidoses are a group of rare inherited disorders that cause the progressive loss of nerve cells in the brain and spinal cord.

Under the milestone-based agreement, Sandoz could pay Henlius up to US$322 million, including near-term payments of up to US$100.5 million linked to the initial assets.

OmniAb was spun out of Ligand Pharmaceuticals in 2022 and has since built a broad network of pharmaceutical partnerships.

The initiative aims to help patients with the greatest medical needs access modern therapies within a coordinated framework that complements the UAE’s national health insurance system.

Through the expanded partnership, Mayo Clinic will clinically integrate Exer AI’s hand and wrist module into its orthopaedic workflows to support musculoskeletal care.

The AI-powered guidance will focus on building sustainable habits related to diet, physical activity, recovery and sleep, helping individuals make informed lifestyle decisions in real time.

The agreement covers joint clinical studies that will combine BeOne’s oncology pipeline with four clinical-stage RAS(ON) inhibitors developed by Revolution Medicines: daraxonrasib, zoldonrasib, elironrasib and RMC-5127.

The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.

Under the agreement, Ono will work with Mediar to identify potential treatments using the biotechnology company’s fibrosis-focused discovery platform and expertise in myofibroblast biology and fibrosis-related pathways.